Bill

Bill > A03823


NY A03823

NY A03823
Adds gabapentin to the prescription monitoring program.


summary

Introduced
01/31/2019
In Committee
01/08/2020
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

2019-2020 General Assembly

Bill Summary

AN ACT to amend the public health law, in relation to adding gabapentin to the prescription monitoring program The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1

AI Summary

This bill amends the Public Health Law to add the drug gabapentin to the Prescription Monitoring Program (PMP) registry. The PMP registry collects and reports information on the prescribing and dispensing of controlled substances and now, under this bill, also gabapentin. The bill requires pharmacies to report information on gabapentin prescriptions to the registry, which will include patient-specific details such as the patient's name, address, date of birth, and gender, as well as the prescription details like the date issued, quantity dispensed, and prescriber information. The bill will take effect on January 1st of the year following its enactment.

Committee Categories

Health and Social Services, Housing and Urban Affairs

Sponsors (24)

Last Action

referred to codes (on 01/08/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...